Erez M. Bublil

991 total citations
20 papers, 773 citations indexed

About

Erez M. Bublil is a scholar working on Rheumatology, Clinical Biochemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Erez M. Bublil has authored 20 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Clinical Biochemistry and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Erez M. Bublil's work include Folate and B Vitamins Research (12 papers), Metabolism and Genetic Disorders (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Erez M. Bublil is often cited by papers focused on Folate and B Vitamins Research (12 papers), Metabolism and Genetic Disorders (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Erez M. Bublil collaborates with scholars based in United States, Israel and Czechia. Erez M. Bublil's co-authors include Yosef Yarden, Tomáš Majtán, Jonathan M. Gershoni, Insun Park, Jan P. Kraus, Natalia T. Freund, Tal Pupko, Osnat Penn, Itay Mayrose and Nimrod D. Rubinstein and has published in prestigious journals such as Journal of Clinical Investigation, Bioinformatics and Biochemistry.

In The Last Decade

Erez M. Bublil

20 papers receiving 755 citations

Peers

Erez M. Bublil

RNMI

ONCOL

RHEUM

BIOCH

P.K. Chiang United States

Christina Meyer United States

R. I. Christopherson Australia

Javier Lizardi Cervera Spain

Richard T. Hamilton United States

Sandra Grau United Kingdom

Paola Ferraro Italy

Stephen J. Zoog United States

Brian Z. Ring United States

James G. Stout United States

P.K. Chiang United States

Erez M. Bublil

558 ×1.3

45 ×0.2

RNMI

165 ×0.8

ONCOL

175 ×1.3

RHEUM

46 ×0.5

BIOCH

Citations per year, relative to Erez M. Bublil Erez M. Bublil (= 1×) peers P.K. Chiang

Countries citing papers authored by Erez M. Bublil

Since Specialization

Citations

This map shows the geographic impact of Erez M. Bublil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erez M. Bublil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erez M. Bublil more than expected).

Fields of papers citing papers by Erez M. Bublil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erez M. Bublil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erez M. Bublil. The network helps show where Erez M. Bublil may publish in the future.

Co-authorship network of co-authors of Erez M. Bublil

This figure shows the co-authorship network connecting the top 25 collaborators of Erez M. Bublil. A scholar is included among the top collaborators of Erez M. Bublil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erez M. Bublil. Erez M. Bublil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levy, Harvey L., Janet A. Thomas, Can Fıçıcıoğlu, et al.. (2022). PEGTIBATINASE, AN INVESTIGATIONAL ENZYME REPLACEMENT THERAPY FOR THE TREATMENT OF CLASSICAL HOMOCYSTINURIA: INITIAL RESULTS FROM THE PHASE 1/2 COMPOSE STUDY. Molecular Genetics and Metabolism. 135(4). 283–284. 1 indexed citations

Park, Insun, Linda K. Johnson, Brian R. Branchford, et al.. (2020). Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria. Biomedicines. 8(8). 244–244. 7 indexed citations

Park, Insun, Helena Hůlková, Jakub Krijt, et al.. (2020). Long‐term uninterrupted enzyme replacement therapy prevents liver disease in murine model of severe homocystinuria. Human Mutation. 41(9). 1662–1670. 7 indexed citations

Park, Insun, Erez M. Bublil, Frank Glavin, & Tomáš Majtán. (2020). Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria. Nutrients. 12(9). 2895–2895. 6 indexed citations

Bublil, Erez M. & Tomáš Majtán. (2019). Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies. Biochimie. 173. 48–56. 27 indexed citations

Majtán, Tomáš, Insun Park, Brian R. Branchford, et al.. (2019). Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine‐restricted diet or enzyme replacement therapy. The FASEB Journal. 33(11). 12477–12486. 18 indexed citations

Majtán, Tomáš, Erez M. Bublil, Insun Park, et al.. (2018). Pharmacokinetics and pharmacodynamics of PEGylated truncated human cystathionine beta-synthase for treatment of homocystinuria. Life Sciences. 200. 15–25. 9 indexed citations

Majtán, Tomáš, Jakub Krijt, Insun Park, et al.. (2017). Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria. Molecular Therapy. 26(3). 834–844. 28 indexed citations

Majtán, Tomáš, et al.. (2017). Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria. Biomacromolecules. 18(6). 1747–1761. 17 indexed citations

10.

Majtán, Tomáš, Insun Park, Erez M. Bublil, & Jan P. Kraus. (2017). Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria. Human Mutation. 39(2). 210–218. 11 indexed citations

11.

Majtán, Tomáš, Helena Hůlková, Insun Park, et al.. (2017). Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria. The FASEB Journal. 31(12). 5495–5506. 22 indexed citations

12.

Bublil, Erez M., Tomer Cohen, Christopher J. Arnusch, et al.. (2016). Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo. Biochemistry. 55(39). 5520–5530. 6 indexed citations

13.

Bublil, Erez M., Tomáš Majtán, Insun Park, et al.. (2016). Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model. Journal of Clinical Investigation. 126(6). 2372–2384. 35 indexed citations

14.

Witsch, Esther, et al.. (2011). Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies. International Immunology. 23(6). 391–403. 9 indexed citations

15.

Bublil, Erez M., Gur Pines, Gargi Patel, et al.. (2010). Kinase‐mediated quasi‐dimers of EGFR. The FASEB Journal. 24(12). 4744–4755. 15 indexed citations

16.

Bublil, Erez M., Gur Pines, Gargi Patel, et al.. (2010). Kinase-mediated quasi-dimers of EGFR. The FASEB Journal. 24(12). 4744–4755. 40 indexed citations

17.

Bublil, Erez M., Natalia T. Freund, Itay Mayrose, et al.. (2007). Stepwise prediction of conformational discontinuous B‐cell epitopes using the Mapitope algorithm. Proteins Structure Function and Bioinformatics. 68(1). 294–304. 71 indexed citations

18.

Bublil, Erez M. & Yosef Yarden. (2007). The EGF receptor family: spearheading a merger of signaling and therapeutics. Current Opinion in Cell Biology. 19(2). 124–134. 306 indexed citations

19.

Mayrose, Itay, Osnat Penn, Nimrod D. Rubinstein, et al.. (2007). Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics. 23(23). 3244–3246. 111 indexed citations

20.

Bublil, Erez M., et al.. (2006). Computational prediction of the cross‐reactive neutralizing epitope corresponding to the monoclonal antibody b12 specific for HIV‐1 gp120. The FASEB Journal. 20(11). 1762–1774. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact